Ovid Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD | 11/13/2025 | 7.53 M | $9.79 M | 0.00% | 10.59% |
| VANGUARD GROUP INC | 11/07/2025 | 2.82 M | $3.67 M | 7.01% | 3.97% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 2.65 M | $3.45 M | 296.99% | 3.73% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 2.29 M | $2.97 M | 8.45% | 3.22% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 2.02 M | $2.62 M | -3.69% | 2.84% |
| SIO CAPITAL MANAGEMENT, LLC | 11/13/2025 | 1.43 M | $1.86 M | -36.04% | 2.01% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.40 M | $1.82 M | 0.00% | 1.97% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 1.35 M | $1.76 M | 17.39% | 1.90% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/13/2025 | 1.11 M | $1.44 M | -26.34% | 1.56% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 1.10 M | $1.42 M | 100.00% | 1.54% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 986.29 K | $1.28 M | -6.28% | 1.39% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 924.58 K | $1.20 M | 112.24% | 1.30% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 883.15 K | $1.15 M | 100.00% | 1.24% |
| MARSHALL WACE, LLP | 11/13/2025 | 783.65 K | $1.02 M | 375.75% | 1.10% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 730.72 K | $949.93 K | -4.25% | 1.03% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 648.02 K | $842.63 K | 0.73% | 0.91% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 625.00 K | $812.50 K | 100.00% | 0.88% |
| BLACKROCK, INC. | 11/12/2025 | 611.32 K | $794.71 K | -55.35% | 0.86% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 596.72 K | $775.73 K | 100.00% | 0.84% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 589.09 K | $765.82 K | 155.86% | 0.83% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 486.88 K | $632.94 K | 100.00% | 0.68% |
| CITADEL ADVISORS LLC | 11/14/2025 | 405.38 K | $527.00 K | 100.00% | 0.57% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 387.51 K | $503.00 K | 100.00% | 0.55% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 362.71 K | $471.52 K | 2,332.97% | 0.51% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 341.13 K | $443.47 K | 100.00% | 0.48% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 265.99 K | $346.00 K | -64.16% | 0.37% |
| JANE STREET GROUP, LLC | 11/14/2025 | 238.42 K | $309.94 K | 67.20% | 0.34% |
| UBS GROUP AG | 11/13/2025 | 237.98 K | $309.37 K | 998.25% | 0.33% |
| STATE STREET CORP | 11/14/2025 | 227.03 K | $295.14 K | 0.00% | 0.32% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 202.98 K | $263.87 K | 100.00% | 0.29% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 188.30 K | $244.78 K | 100.00% | 0.26% |
| DIADEMA PARTNERS LP | 11/14/2025 | 187.74 K | $244.06 K | 100.00% | 0.26% |
| XTX TOPCO LTD | 11/14/2025 | 183.30 K | $238.29 K | 133.74% | 0.26% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2025 | 160.00 K | $208.00 K | 0.00% | 0.23% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 151.80 K | $197.34 K | 100.00% | 0.21% |
| NORTHERN TRUST CORP | 11/14/2025 | 151.71 K | $197.22 K | 53.06% | 0.21% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 114.92 K | $149.40 K | -48.03% | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 95.43 K | $124.06 K | 0.00% | 0.13% |
| EMPOWERED FUNDS, LLC | 11/13/2025 | 91.23 K | $118.60 K | 0.00% | 0.13% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 86.65 K | $112.65 K | 2,136.76% | 0.12% |
| CITADEL ADVISORS LLC | 11/14/2025 | 78.50 K | $102.05 K | 403.21% | 0.11% |
| CITADEL ADVISORS LLC | 11/14/2025 | 62.50 K | $81.25 K | 100.00% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 58.10 K | $75.53 K | 100.00% | 0.08% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 57.70 K | $75.01 K | 0.00% | 0.08% |
| INTEGRATED WEALTH CONCEPTS LLC | 11/14/2025 | 52.90 K | $68.77 K | 100.00% | 0.07% |
| FMR LLC | 11/13/2025 | 46.99 K | $61.08 K | 0.00% | 0.07% |
| PERSISTENT ASSET PARTNERS LTD | 11/10/2025 | 46.04 K | $59.85 K | 100.00% | 0.06% |
| ABEL HALL, LLC | 11/17/2025 | 32.35 K | $42.05 K | 0.00% | 0.05% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 28.52 K | $37.07 K | -89.95% | 0.04% |
| QUADRATURE CAPITAL LTD | 11/13/2025 | 27.70 K | $35.88 K | 100.00% | 0.04% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ovid Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 110 institutional investors and hedge funds held shares of Ovid Therapeutics Inc.. The most heavily invested institutionals were:
TAKEDA PHARMACEUTICAL CO LTD: 7.53 M
VANGUARD GROUP INC: 2.82 M
Affinity Asset Advisors, LLC: 2.65 M
ACADIAN ASSET MANAGEMENT LLC: 2.29 M
RENAISSANCE TECHNOLOGIES LLC: 2.02 M
Sio Capital Management, LLC: 1.43 M
50.92% of Ovid Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 42.42 M shares in the last 24 months. This purchase volume represents approximately $78.06 M in transactions.